Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT:SIPHA)

Tunisia flag Tunisia · Delayed Price · Currency is TND
4.080
-0.190 (-4.45%)
At close: Jun 4, 2026
Market Cap7.34M -11.1%
Revenue (ttm)20.23M -35.1%
Net Income-17.10M
EPS-9.50
Shares Out 1.80M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6
Open4.080
Previous Close4.270
Day's Range4.080 - 4.080
52-Week Range3.450 - 6.250
Beta-0.86
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BVMT:SIPHA

Société des Industries Pharmaceutiques de Tunisie - S.A. engages in the research, development, manufacture, packaging, and marketing of pharmaceutical products for human use in Tunisia and internationally. It provides rheumatology drugs, such as MYORELAX, NIFLUMIC, and ALGESAL SURACTIVE; stomatology drugs, including HEXABAIN; and ANALGAN CODEINE 300mg/25mg indicated for the symptomatic treatment of moderate and intense pain. The company was founded in 1989 and is headquartered in Ben Arous, Tunisia. [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 744
Stock Exchange Tunis Stock Exchange
Ticker Symbol SIPHA
Full Company Profile